Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Yifei Liu, BS Pharm, PhD
Advertisement
Articles by Yifei Liu, BS Pharm, PhD
Advertisement
Latest Updated Articles
- Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital
Published: October 5th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
